Un­per­suad­ed by the da­ta, FDA re­jects cheap, gener­ic SS­RI as a Covid-19 drug

Flu­vox­am­ine, an SS­RI al­ready FDA-ap­proved as an OCD treat­ment, ap­peared to show some hints of ef­fi­ca­cy in Covid-19 too, lead­ing Uni­ver­si­ty of Min­neso­ta ID doc …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER